Woodline Partners LP Dice Therapeutics, Inc. Transaction History

Woodline Partners LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $5.13 Million - $6.37 Million	197,048 Added 19.8%	1,192,177 $34.2 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $10.1 Million - $21.6 Million	511,385 Added 105.71%	995,129 $31 Million
Q3 2022 Nov 14, 2022	SELL	$14.97 - $22.65 $2.29 Million - $3.47 Million	-153,243 Reduced 24.06%	483,744 $9.81 Million
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $160,469 - $268,868	-12,166 Reduced 1.87%	636,987 $9.89 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $5.8 Million - $9.99 Million	399,104 Added 159.61%	649,153 $12.4 Million
Q4 2021 Feb 14, 2022	SELL	$22.41 - $37.54 $201 - $337	-9 Reduced -0.0%	250,049 $6.33 Million
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $7.98 Million - $9.25 Million	250,058 New	250,058 $8.19 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.